HealthEquity, Inc. (HQY)

NASDAQ: HQY · Real-Time Price · USD

100.97

+3.09 (3.16%)

At close: Oct 22, 2026, 4:00 PM EDT

100.97

0.00 (0.00%)

Pre-market: Oct 23, 2026, 4:08 AM EDT

HealthEquity Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Market Capitalization	8,352	7,319	9,569	6,485	5,150	4,468
Market Cap Growth	4.20%	-23.51%	47.56%	25.91%	15.28%	-30.55%
Enterprise Value	9,067	8,038	10,382	7,085	5,938	4,829
Last Close Price	100.97	85.67	110.42	75.58	60.85	53.44

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
PE Ratio	36.54	34.01	98.96	116.40	-	-
Forward PE	19.95	19.75	31.70	28.55	36.76	40.27
PS Ratio	6.13	5.57	7.98	6.49	5.98	5.91
PB Ratio	4.21	3.47	4.53	3.19	2.72	2.41
P/FCF Ratio	17.12	16.08	28.33	26.89	34.97	33.82
P/OCF Ratio	17.04	16.01	28.16	26.71	34.19	31.69
PEG Ratio	1.24	1.16	1.28	1.17	1.33	3.58

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
EV/Sales Ratio	6.66	6.12	8.65	7.09	6.89	6.38
EV/EBITDA Ratio	17.65	16.67	28.42	25.20	29.86	27.17
EV/EBIT Ratio	25.47	24.55	51.18	55.30	157.71	119.04
EV/FCF Ratio	18.59	17.66	30.74	29.38	40.32	36.56

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Debt / Equity Ratio	0.49	0.48	0.52	0.46	0.53	0.54
Debt / EBITDA Ratio	1.88	2.06	2.99	3.24	4.78	5.29
Debt / FCF Ratio	1.99	2.20	3.28	3.87	6.75	7.63
Net Debt / Equity Ratio	0.36	0.32	0.38	0.26	0.39	0.42
Net Debt / EBITDA Ratio	1.39	1.42	2.22	1.88	3.72	4.40
Net Debt / FCF Ratio	1.47	1.50	2.41	2.19	5.03	5.93
Asset Turnover	0.41	0.39	0.36	0.32	0.28	0.26
Quick Ratio	2.46	2.82	2.65	4.35	2.68	2.04
Current Ratio	2.99	3.27	3.06	4.76	2.92	2.29
Return on Equity (ROE)	11.43%	10.19%	4.66%	2.83%	-1.40%	-2.74%
Return on Assets (ROA)	6.65%	5.99%	3.84%	2.56%	0.76%	0.87%
Return on Invested Capital (ROIC)	9.97%	8.89%	6.16%	3.66%	1.43%	1.70%
Return on Capital Employed (ROCE)	11.40%	10.20%	6.20%	4.20%	1.30%	1.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Earnings Yield	2.74%	2.94%	1.01%	0.86%	-0.51%	-0.99%
FCF Yield	5.84%	6.22%	3.53%	3.72%	2.86%	2.96%
Buyback Yield / Dilution	3.29%	1.52%	-2.15%	-2.98%	-1.57%	-9.85%

SEC Filings: 10-K · 10-Q